PubMed 28068222 Regulatory status: NAD+ itself is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL)
As the CNS-VS test documented, his cognitive function improved from April 2022 to December 2023
5.3 Theranostic nanoparticles: dual functionality for diagnosis and therapy Theranostics, which integrate therapeutic and diagnostic methodologies, are anticipated to transform personalized medicine by facilitating concurrent monitoring and treatment of breast cancer at cellular or molecular levels
heteroalkyl includes a chain of atoms that includes both carbon and at least one heteroatom, and is optionally branched
Some practitioners also monitor free T3 levels, particularly if you experience symptoms despite normal TSH and free T4 values
That's the baseline this article is evaluating HumeCare+ against - not a claim that HumeCare+ specifically outperforms other named competitors, since competing programs' clinical protocols were not independently reviewed for this comparison